LevodopaCarbidopaEntacapon

Hauptinformation

  • Handelsname:
  • Levodopa/Carbidopa/Entacapon Hormosan 125 mg/31,25 mg/200 mg Filmtabletten
  • Darreichungsform:
  • Filmtablette
  • Zusammensetzung:
  • Levodopa 125.mg; Carbidopa-Monohydrat 33.74mg; Entacapon 200.mg
  • Verwenden für:
  • Menschen
  • Art der Medizin:
  • allopathic Droge

Dokumenten

  • für die Allgemeinheit:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie das Informationsblatt für die Öffentlichkeit.

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Levodopa/Carbidopa/Entacapon Hormosan 125 mg/31,25 mg/200 mg Filmtabletten
    Deutschland
  • Sprache:
  • Deutsch

Weitere Informationen

Status

  • Quelle:
  • BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte
  • Zulassungsnummer:
  • 96636.00.00
  • Letzte Änderung:
  • 11-03-2018

7-5-2018

Broschüre für den Arzt

Broschüre für den Arzt

Carbidopa/Levodopa - Duodopa - Information für Ärzte

Deutschland - BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte

7-5-2018

Broschüre für den Patienten

Broschüre für den Patienten

Carbidopa/Levodopa - Duodopa - Information für Patienten

Deutschland - BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte

3-8-2017

FDA Drug Safety Communication: Ongoing Safety Review of Stalevo (entacapone/carbidopa/levodopa) and possible development of Prostate Cancer

FDA Drug Safety Communication: Ongoing Safety Review of Stalevo (entacapone/carbidopa/levodopa) and possible development of Prostate Cancer

[03-31-2010] The U.S. Food and Drug Administration (FDA) is evaluating clinical trial data that may suggest that patients taking Stalevo, a Parkinson's disease medication, may be at an increased risk for developing prostate cancer.

FDA - U.S. Food and Drug Administration

24-4-2018

Levodopa/Carbidopa/Entacapone Orion

Rote - Liste

19-4-2018

Sinemet vs. Parcopa

Sinemet vs. Parcopa

Sinemet (carbidopa-levodopa) and Parcopa (carbidopa and levodopa) are combinations of an inhibitor of aromatic amino acid decarboxylation and an aromatic amino acid used to treat Parkinson symptoms such as muscle stiffness, tremors, spasms, and poor muscle control. Sinemet and Parcopa are also used to treat Parkinson symptoms caused by carbon monoxide poisoning or manganese intoxication.

US - RxList

19-4-2018

Sinemet vs. Requip

Sinemet vs. Requip

Sinemet (carbidopa-levodopa) and Requip (ropinirole) are used to treat Parkinson symptoms such as muscle stiffness, tremors, spasms, and poor muscle control. Sinemet is also used to treat Parkinson symptoms caused by carbon monoxide poisoning or manganese intoxication. Requip is also used to treat restless legs syndrome (RLS).

US - RxList

19-4-2018

Sinemet vs. Rytary

Sinemet vs. Rytary

Sinemet (carbidopa-levodopa) and Rytary (carbidopa and levodopa) are combinations of an inhibitor of aromatic amino acid decarboxylation and an aromatic amino acid used to treat Parkinson symptoms such as muscle stiffness, tremors, spasms, and poor muscle control. Sinemet and Rytary are also used to treat Parkinson symptoms caused by carbon monoxide poisoning or manganese intoxication.

US - RxList

19-4-2018

Sinemet vs. Stalevo

Sinemet vs. Stalevo

Sinemet (carbidopa-levodopa) and Stalevo (carbidopa, levodopa, and entacapone) are combination drugs used to treat Parkinson symptoms such as muscle stiffness, tremors, spasms, and poor muscle control. Sinemet is also used to treat Parkinson symptoms caused by carbon monoxide poisoning or manganese intoxication.

US - RxList

4-4-2018

CARBIDOPA AND LEVODOPA Tablet [Preferred Pharmaceuticals, Inc.]

CARBIDOPA AND LEVODOPA Tablet [Preferred Pharmaceuticals, Inc.]

Updated Date: Apr 4, 2018 EST

US - DailyMed

27-12-2017

CARBIDOPA AND LEVODOPA Tablet [Carilion Materials Management]

CARBIDOPA AND LEVODOPA Tablet [Carilion Materials Management]

Updated Date: Dec 27, 2017 EST

US - DailyMed

21-12-2017

CARBIDOPA AND LEVODOPA Tablet [Mayne Pharma Inc.]

CARBIDOPA AND LEVODOPA Tablet [Mayne Pharma Inc.]

Updated Date: Dec 21, 2017 EST

US - DailyMed

14-12-2017

DUOPA (Carbidopa And Levodopa) Suspension [AbbVie Inc.]

DUOPA (Carbidopa And Levodopa) Suspension [AbbVie Inc.]

Updated Date: Dec 14, 2017 EST

US - DailyMed

11-12-2017

CARBIDOPA AND LEVODOPA Tablet [Actavis Pharma, Inc.]

CARBIDOPA AND LEVODOPA Tablet [Actavis Pharma, Inc.]

Updated Date: Dec 11, 2017 EST

US - DailyMed

7-11-2017

Carbidopa/Levodopa

Carbidopa/Levodopa

Carbidopa/levodopa is a combination of an inhibitor of aromatic amino acid decarboxylation and an aromatic amino acid used to treat Parkinson symptoms such as muscle stiffness, tremors, spasms, and poor muscle control.

US - RxList

18-10-2017

CARBIDOPA AND LEVODOPA Tablet [Aphena Pharma Solutions - Tennessee, LLC]

CARBIDOPA AND LEVODOPA Tablet [Aphena Pharma Solutions - Tennessee, LLC]

Updated Date: Oct 18, 2017 EST

US - DailyMed

18-10-2017

CARBIDOPA AND LEVODOPA Tablet [Golden State Medical Supply, Inc.]

CARBIDOPA AND LEVODOPA Tablet [Golden State Medical Supply, Inc.]

Updated Date: Oct 18, 2017 EST

US - DailyMed

6-10-2017

CARBIDOPA AND LEVODOPA Tablet [American Health Packaging]

CARBIDOPA AND LEVODOPA Tablet [American Health Packaging]

Updated Date: Oct 6, 2017 EST

US - DailyMed

1-9-2017

CARBIDOPA AND LEVODOPA Tablet, Extended Release [American Health Packaging]

CARBIDOPA AND LEVODOPA Tablet, Extended Release [American Health Packaging]

Updated Date: Sep 1, 2017 EST

US - DailyMed

29-8-2017

CARBIDOPA AND LEVODOPA Tablet [NuCare Pharmaceuticals,Inc.]

CARBIDOPA AND LEVODOPA Tablet [NuCare Pharmaceuticals,Inc.]

Updated Date: Aug 29, 2017 EST

US - DailyMed

31-7-2017

CARBIDOPA AND LEVODOPA Tablet, Orally Disintegrating [Sun Pharma Global FZE]

CARBIDOPA AND LEVODOPA Tablet, Orally Disintegrating [Sun Pharma Global FZE]

Updated Date: Jul 31, 2017 EST

US - DailyMed

31-7-2017

CARBIDOPA AND LEVODOPA Tablet [Sun Pharmaceutical Industries Limited ]

CARBIDOPA AND LEVODOPA Tablet [Sun Pharmaceutical Industries Limited ]

Updated Date: Jul 31, 2017 EST

US - DailyMed

26-7-2017

CARBIDOPA (Carbidopa Tablets) Tablet [Oceanside Pharmaceuticals]

CARBIDOPA (Carbidopa Tablets) Tablet [Oceanside Pharmaceuticals]

Updated Date: Jul 26, 2017 EST

US - DailyMed

18-7-2017

CARBIDOPA AND LEVODOPA Tablet [Unit Dose Services]

CARBIDOPA AND LEVODOPA Tablet [Unit Dose Services]

Updated Date: Jul 18, 2017 EST

US - DailyMed

17-7-2017

Carbidopa

Carbidopa

Carbidopa is a prescription drug used in treatment of Parkinson’s disease, postencephalitic parkinsonism, and symptomatic parkinsonism.

US - RxList

28-6-2017

CARBIDOPA AND LEVODOPA Tablet [McKesson Corporation]

CARBIDOPA AND LEVODOPA Tablet [McKesson Corporation]

Updated Date: Jun 28, 2017 EST

US - DailyMed

22-6-2017

CARBIDOPA AND LEVODOPA Tablet [Bryant Ranch Prepack]

CARBIDOPA AND LEVODOPA Tablet [Bryant Ranch Prepack]

Updated Date: Jun 22, 2017 EST

US - DailyMed